Lexaria Bioscience Corp.

Lexaria Bioscience Corp. financial statements

Lexaria Bioscience Corp.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

FY2025

RevenueUSD 705.92K10-K
Net income−USD 11.9M10-K
Cash and equivalentsUSD 1.8M10-Q

Lexaria Bioscience Corp. financials on 6ix · Lexaria Bioscience Corp. on 6ix